APA ציטוט

Ozawa, H., Ranaweera, R., Izumchenko, E., Makarev, E., Zhavoronkov, A., Fertig, E. J., . . . Chung, C. H. (2017). SMAD4 loss is associated with cetuximab resistance and induction of MAPK/JNK activation in head and neck cancer cells. Clin Cancer Res.

Citação norma Chicago

Ozawa, Hiroyuki, et al. "SMAD4 Loss Is Associated With Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer Cells." Clin Cancer Res 2017.

ציטוט MLA

Ozawa, Hiroyuki, et al. "SMAD4 Loss Is Associated With Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer Cells." Clin Cancer Res 2017.